Hospira Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (42)

Latest Posts

About This Stock More About This Stock
These 4 Resilient Stocks Survived Monday's Selloff
Article By: Zacks Investment Research
Wednesday, August 26, 2015 6:58 AM EDT
On Monday, almost all the 500 members of the S & P settled in negative territory. The S&P along with the blue-chip index posted their biggest one-day percentage declines on Monday since Aug 2011.
In this article: HSP, SWKS, UNTD Also: PFE
Read
Dow 30 Performance Last Week & Next Week's Outlook
Article By: Zacks Investment Research
Sunday, August 2, 2015 7:57 PM EDT
The Dow experienced another difficult week, weighed down again by disappointing earnings and international concerns. As more earnings data and several important economic reports are released this week, they will continue to influence stock movement.
In this article: BA, CVX, DD, GS, HSP, MRK, PFE, PG, XOM, EADSY, AAPL, MSFT
Read
CVS Health Q1 Earnings Beat, Grow Y/Y; EPS View Raised
Article By: Zacks Investment Research
Friday, May 1, 2015 12:05 PM EDT
CVS Health posted yet another solid quarter with both earnings and revenues exceeding the respective Consensus Estimate by decent margins.
In this article: CVS, HSP, SRDX, LMAT
Read
3 Biotech Stocks Under $10 With Amazing Growth Prospects
Article By: Zacks Investment Research
Wednesday, April 15, 2015 12:03 PM EDT
The biotech sector is witnessing changing dynamics with the focus shifting from large caps to smaller companies with high growth potential.
In this article: GERN, HSP, PFE, GILD, AMGN, ESRX, NVS, JNJ, ABBV, PCYC, ANTH
Read
Best Rated Technology Mutual Funds To Buy Now
Article By: Zacks Investment Research
Tuesday, March 31, 2015 2:37 PM EDT
Below we will share with you 5 best rated technology mutual funds. Each has earned a Zacks #1 Rank (Strong Buy) as we expect these mutual funds to outperform their peers in the future.
In this article: LRCX, SLMCX, FSELX, USSCX, BUFTX, KTCAX, HSP
Read

Latest Tweets for $HSP

No tweets yet!

PARTNER HEADLINES